REQUEST A DEMO
Total
USD $0.00
Search more companies

Ansh Therapeutics Private Limited (India)

Main Activities: Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
Full name: Ansh Therapeutics Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Ansh Therapeutics Private Limited is an unlisted company, incorporated on 24/06/2010. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U33110DL2010PTC204655 and registration number is 204655. The company is a trade company, it is engaged in wholesale trading.

Legal Address
220/1, First Floor Nangal Raya
South West Delhi; Delhi; Postal Code: 110046

Contact Details: Purchase the Ansh Therapeutics Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ansh Therapeutics Private Limited report to view the information.
Registered Capital:
Purchase the Ansh Therapeutics Private Limited report to view the information.
Incorporation Date:
June 24, 2010
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Ansh Therapeutics Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
14.86%
Total operating revenue
15.12%
Operating profit (EBIT)
55.02%
EBITDA
48.73%
Net Profit (Loss) for the Period
54.8%
Total assets
41.79%
Total equity
68.99%
Operating Profit Margin (ROS)
3.11%
Net Profit Margin
2.3%
Return on Equity (ROE)
-3.78%
Debt to Equity Ratio
-24.93%
Quick Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?